The results of ELISA demonstrated that the median serum Ang2 levels in control, CLD, and HCC patients were 1.99, 2.26, and 3.83 ng/mL, respectively (Fig. 1A). The gene discussed is ANGPT2; the disease is hepatocellular carcinoma.